Literature DB >> 8253155

Onchocerca volvulus: characterization of an immunodominant hypodermal antigen present in adult and larval parasites.

J E Bradley1, R S Tuan, K J Shepley, T I Tree, R M Maizels, R Helm, W F Gregory, T R Unnasch.   

Abstract

Biochemical and immunological data suggest that a relatively limited number of polypeptide antigens of viable Onchocerca volvulus-infective larvae are available to be recognized by the host's immune system. A partial cDNA clone encoding one such antigen, designated lambda RAL-2, was isolated by screening an expression cDNA library with antisera raised against viable O. volvulus L3. The antigen encoded by this clone was subsequently found to be immunogenic in the majority of individuals exposed to O. volvulus. In the present study, the native antigen corresponding to lambda RAL-2 (Ov17) has been characterized. Immunolocalization and in situ hybridization techniques have been used to localize Ov17 in adult and larval stages of the parasite. In adult females, Ov17 was localized primarily in the hypodermis. Ov17 was accessible to surface labeling reagents in viable adult parasites. Full-length cDNA clones encoding Ov17 suggested that the nascent protein contains a putative leader sequence, which is almost immediately followed by a polyglutamine tract. Analysis of antibody reactivity to recombinant proteins containing and lacking the polyglutamine tract demonstrated that this structure was not a significant B cell epitope in individuals exposed to O. volvulus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253155     DOI: 10.1006/expr.1993.1101

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  10 in total

1.  Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries.

Authors:  M Lizotte-Waniewski; W Tawe; D B Guiliano; W Lu; J Liu; S A Williams; S Lustigman
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16.

Authors:  Ricardo T Fujiwara; Bin Zhan; Susana Mendez; Alex Loukas; Lilian L Bueno; Yan Wang; Jordan Plieskatt; Yelena Oksov; Sara Lustigman; Maria Elena Bottazzi; Peter Hotez; Jeffrey M Bethony
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

3.  Intranasal immunization with recombinant Ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A. suum infection in mice.

Authors:  N Tsuji; K Suzuki; H Kasuga-Aoki; Y Matsumoto; T Arakawa; K Ishiwata; T Isobe
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Characterizing Reactivity to Onchocerca volvulus Antigens in Multiplex Bead Assays.

Authors:  Karla R Feeser; Vitaliano Cama; Jeffrey W Priest; Elizabeth A Thiele; Ryan E Wiegand; Thomson Lakwo; Sindew M Feleke; Paul T Cantey
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

5.  The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.

Authors:  Fidelis Cho-Ngwa; Jing Liu; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2010-08-24

6.  Development of a Multiplex Bead Assay for the Detection of IgG Antibody Responses to Guinea Worm.

Authors:  Jeffrey W Priest; Olga Stuchlik; Matthew Reed; Peter Soboslay; Vitaliano Cama; Sharon L Roy
Journal:  Am J Trop Med Hyg       Date:  2020-09-03       Impact factor: 3.707

7.  An Integrated Multiomics Approach to Identify Candidate Antigens for Serodiagnosis of Human Onchocerciasis.

Authors:  Samantha N McNulty; Bruce A Rosa; Peter U Fischer; Jeanne M Rumsey; Petra Erdmann-Gilmore; Kurt C Curtis; Sabine Specht; R Reid Townsend; Gary J Weil; Makedonka Mitreva
Journal:  Mol Cell Proteomics       Date:  2015-10-15       Impact factor: 5.911

Review 8.  Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi.

Authors:  Bin Zhan; Maria Elena Bottazzi; Peter J Hotez; Sara Lustigman
Journal:  Front Cell Infect Microbiol       Date:  2022-04-04       Impact factor: 6.073

9.  The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.

Authors:  Jessica A Hess; Bin Zhan; April R Torigian; John B Patton; Nikolai Petrovsky; Tingting Zhan; Maria Elena Bottazzi; Peter J Hotez; Thomas R Klei; Sara Lustigman; David Abraham
Journal:  PLoS Negl Trop Dis       Date:  2016-07-07

10.  Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection.

Authors:  Sridhar Arumugam; Junfei Wei; Zhuyun Liu; David Abraham; Aaron Bell; Maria Elena Bottazzi; Peter J Hotez; Bin Zhan; Sara Lustigman; Thomas R Klei
Journal:  PLoS Negl Trop Dis       Date:  2016-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.